Skip to content

F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00180193
Enrollment
40
Registered
2005-09-16
Start date
2003-12-31
Completion date
Unknown
Last updated
2009-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor

Keywords

Radiotherapy, F-18-OMFD

Brief summary

The purpose of this study is to monitor the amino acid uptake of brain tumors, before and during radiotherapy, with positron emission tomography.

Interventions

None listed

Sponsors

Advanced Biochemical Compounds GmbH
CollaboratorINDUSTRY
Technische Universität Dresden
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Brain tumor * Radiation therapy indicated * Written consent

Exclusion criteria

* Pregnancy * Mental impairment * Drug/alcohol abuse

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026